298 related articles for article (PubMed ID: 32565043)
1. Evaluation of causality between ADHD and Parkinson's disease: Mendelian randomization study.
Li GH; Ge GM; Cheung CL; Ip P; Coghill D; Wong IC
Eur Neuropsychopharmacol; 2020 Aug; 37():49-63. PubMed ID: 32565043
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
Kia DA; Noyce AJ; White J; Speed D; Nicolas A; ; Burgess S; Lawlor DA; Davey Smith G; Singleton A; Nalls MA; Sofat R; Wood NW
Ann Neurol; 2018 Aug; 84(2):191-199. PubMed ID: 30014513
[TBL] [Abstract][Full Text] [Related]
3. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
Front Immunol; 2022; 13():956005. PubMed ID: 36159838
[TBL] [Abstract][Full Text] [Related]
4. The Parkinson's Disease Mendelian Randomization Research Portal.
Noyce AJ; Bandres-Ciga S; Kim J; Heilbron K; Kia D; Hemani G; Xue A; Lawlor DA; Smith GD; Duran R; Gan-Or Z; Blauwendraat C; Gibbs JR; ; Hinds DA; Yang J; Visscher P; Cuzick J; Morris H; Hardy J; Wood NW; Nalls MA; Singleton AB
Mov Disord; 2019 Dec; 34(12):1864-1872. PubMed ID: 31659794
[TBL] [Abstract][Full Text] [Related]
5. Assessing causality in the association between attention-deficit/hyperactivity disorder and obesity: a Mendelian randomization study.
Martins-Silva T; Vaz JDS; Hutz MH; Salatino-Oliveira A; Genro JP; Hartwig FP; Moreira-Maia CR; Rohde LA; Borges MC; Tovo-Rodrigues L
Int J Obes (Lond); 2019 Dec; 43(12):2500-2508. PubMed ID: 31000774
[TBL] [Abstract][Full Text] [Related]
6. Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization.
Treur JL; Demontis D; Smith GD; Sallis H; Richardson TG; Wiers RW; Børglum AD; Verweij KJH; Munafò MR
Addict Biol; 2021 Jan; 26(1):e12849. PubMed ID: 31733098
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder and ischemic stroke: A Mendelian randomization study.
Du R; Zhou Y; You C; Liu K; King DA; Liang ZS; Ranson JM; Llewellyn DJ; Huang J; Zhang Z
Int J Stroke; 2023 Mar; 18(3):346-353. PubMed ID: 35670701
[TBL] [Abstract][Full Text] [Related]
8. Associations between polyunsaturated fatty acid concentrations and Parkinson's disease: A two-sample Mendelian randomization study.
Zhu X; Huang S; Kang W; Chen P; Liu J
Front Aging Neurosci; 2023; 15():1123239. PubMed ID: 36909950
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's Disease and Ischemic Stroke: a Bidirectional Mendelian Randomization Study.
Fang S; Hu X; Wang T; Yang Y; Xu R; Zhang X; Luo J; Ma Y; Patel AB; Dmytriw AA; Jiao L
Transl Stroke Res; 2022 Aug; 13(4):528-532. PubMed ID: 35013977
[TBL] [Abstract][Full Text] [Related]
10. Genetic correlation and causal associations between psychiatric disorders and lung cancer risk.
Shi J; Wen W; Long J; Gamazon ER; Tao R; Cai Q
J Affect Disord; 2024 Jul; 356():647-656. PubMed ID: 38657774
[TBL] [Abstract][Full Text] [Related]
11. Evidence for genetic causality between iron homeostasis and Parkinson's disease: A two-sample Mendelian randomization study.
Chen H; Wang X; Chang Z; Zhang J; Xie D
J Trace Elem Med Biol; 2024 Jul; 84():127430. PubMed ID: 38484633
[TBL] [Abstract][Full Text] [Related]
12. Fetal Origins of Mental Disorders? An Answer Based on Mendelian Randomization.
Arafat S; Minică CC
Twin Res Hum Genet; 2018 Dec; 21(6):485-494. PubMed ID: 30587273
[TBL] [Abstract][Full Text] [Related]
13. Mendelian Randomization Analysis Reveals No Causal Relationship Between Plasma α-Synuclein and Parkinson's Disease.
Zhang Q; Lin Z; He Y; Jiang J; Hu D
Mol Neurobiol; 2023 Apr; 60(4):2268-2276. PubMed ID: 36640248
[TBL] [Abstract][Full Text] [Related]
14. The impact and causal directions for the associations between diagnosis of ADHD, socioeconomic status, and intelligence by use of a bi-directional two-sample Mendelian randomization design.
Michaëlsson M; Yuan S; Melhus H; Baron JA; Byberg L; Larsson SC; Michaëlsson K
BMC Med; 2022 Apr; 20(1):106. PubMed ID: 35399077
[TBL] [Abstract][Full Text] [Related]
15. Genetic causal relationship between multiple immune cell phenotypes and Parkinson's disease: a two-sample bidirectional Mendelian randomization study.
Chen H; Wang X; Chang Z; Zhang J; Xie D
J Neurophysiol; 2024 Jun; 131(6):1115-1125. PubMed ID: 38690999
[TBL] [Abstract][Full Text] [Related]
16. Investigating the causality of metabolites involved in one-carbon metabolism with the risk and age at onset of Parkinson's disease: A two-sample mendelian randomization study.
Zhao Y; Tian D; Guo N; Zhang C; Zhu R; Liu X; Zhang J
Neurobiol Aging; 2021 Dec; 108():196-199. PubMed ID: 34325950
[TBL] [Abstract][Full Text] [Related]
17. Bidirectional Mendelian randomization to explore the causal relationships between Sleep traits, Parkinson's disease and Amyotrophic lateral sclerosis.
Di H; Zhu Y; Xia W; Meng X; Zhang M; Xu M; Feng J; Tian Q; He Y; Cao S; Lu Z
Sleep Med; 2022 Aug; 96():42-49. PubMed ID: 35594779
[TBL] [Abstract][Full Text] [Related]
18. Assessment of causal factors for Parkinson's disease in European populations: A phenome-wide Mendelian randomisation analysis.
Xue Z; Cheng Y; Yu Q; Wang T; Fan C; Zou Z; Zhang X
Asia Pac J Clin Nutr; 2021 Jun; 30(2):329-339. PubMed ID: 34191436
[TBL] [Abstract][Full Text] [Related]
19. Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study.
Liu H; Zhang Y; Zhang H; Wang L; Wang T; Han Z; Wu L; Liu G
J Transl Med; 2021 May; 19(1):221. PubMed ID: 34030714
[TBL] [Abstract][Full Text] [Related]
20. No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.
Larsson SC; Singleton AB; Nalls MA; Richards JB;
Mov Disord; 2017 Aug; 32(8):1249-1252. PubMed ID: 28594127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
